HR 3546 · 109th Congress · Health

Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005

Introduced 2005-07-28· Sponsored by Rep. Emanuel, Rahm [D-IL-5]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2005-08-05)

Plain Language Summary

[AI summary unavailable — showing source text] Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005 - Amends title XIX (Medicaid) of the Social Security Act to require the Secretary of Health and Human Services to disclose publicly the average manufacturer prices (AMP) and best prices for prescription drugs. Requires each drug manufacturer with a rebate agreement in effect to report to the Secretary detailed information (specified by the Secretary) on how the AMP is computed, including assumptions used.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (16)

15 Democrats1 Independent
Rep. Case, Ed [D-HI-2]HI
Rep. Lipinski, Daniel [D-IL-3]IL
Rep. Herseth, Stephanie [D-SD-At Large]SD
Rep. Doggett, Lloyd [D-TX-25]TX
Rep. McCarthy, Carolyn [D-NY-4]NY
Rep. Berry, Marion [D-AR-1]AR
Rep. Owens, Major R. [D-NY-11]NY
Rep. McNulty, Michael R. [D-NY-21]NY
Rep. Solis, Hilda L. [D-CA-32]CA
Rep. Conyers, John, Jr. [D-MI-14]MI
Rep. Hinchey, Maurice D. [D-NY-22]NY
Rep. Wexler, Robert [D-FL-19]FL
Rep. Farr, Sam [D-CA-17]CA
Rep. Sanders, Bernard [I-VT-At Large]VT
Rep. Woolsey, Lynn C. [D-CA-6]CA
Rep. McDermott, Jim [D-WA-7]WA